Teva acquires Emalex Biosciences for up to $900m
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced it has signed a definitive agreement to acquire Emalex ...
Saturday, August 1, 2026
Tag: Emalex
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.